We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Vistra Energy (VST) to Report Q4 Earnings: What's in the Offing?
Read MoreHide Full Article
Vistra Energy Corp. (VST - Free Report) is scheduled to release fourth-quarter results on Feb 26, before the market opens. In the last reported quarter, the company delivered an earnings surprise of 155.6%, on average.
Let’s discuss the factors that are likely to get reflected in the upcoming quarterly results.
Factors to Consider
Vistra Energy’s fourth-quarter earnings are likely to have benefited from the repayment of $1,150-million debt till Sep 30, 2020, which is also expected to have lowered capital servicing costs.
Retail power prices returned to moderate levels in the fourth quarter, which in turn must have resulted in higher gross margins. Vistra Energy is also anticipated to have benefited from higher residential volumes due to substantial work-at-home population.
Expectation
The Zacks Consensus Estimate for fourth-quarter earnings per share is pegged at $1.40, which indicates an increase of 180% from the year-ago reported figure.
What the Zacks Model Says
Our proven model doesn’t conclusively predict an earnings beat for Vistra Energy this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here as elaborated below. You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: It has an Earnings ESP of -40.71%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Currently, Vistra Energy carries a Zacks Rank #3.
Stocks to Consider
Investors can consider the following players from the same sector that have the right combination of elements to beat on earnings this season.
Essential Utilities, Inc. (WTRG - Free Report) is set to release fourth-quarter earnings on Feb 24. It has an Earnings ESP of +3.60% and a Zacks Rank of 3, currently.
CenterPoint Energy, Inc. (CNP - Free Report) is expected to release fourth-quarter numbers on Feb 25. It has an Earnings ESP of +11.11% and a Zacks Rank #3, at present.
Sempra Energy (SRE - Free Report) is expected to release fourth-quarter numbers on Feb 25. It has an Earnings ESP of +6.45% and a Zacks Rank #3, at present.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Vistra Energy (VST) to Report Q4 Earnings: What's in the Offing?
Vistra Energy Corp. (VST - Free Report) is scheduled to release fourth-quarter results on Feb 26, before the market opens. In the last reported quarter, the company delivered an earnings surprise of 155.6%, on average.
Let’s discuss the factors that are likely to get reflected in the upcoming quarterly results.
Factors to Consider
Vistra Energy’s fourth-quarter earnings are likely to have benefited from the repayment of $1,150-million debt till Sep 30, 2020, which is also expected to have lowered capital servicing costs.
Retail power prices returned to moderate levels in the fourth quarter, which in turn must have resulted in higher gross margins. Vistra Energy is also anticipated to have benefited from higher residential volumes due to substantial work-at-home population.
Expectation
The Zacks Consensus Estimate for fourth-quarter earnings per share is pegged at $1.40, which indicates an increase of 180% from the year-ago reported figure.
What the Zacks Model Says
Our proven model doesn’t conclusively predict an earnings beat for Vistra Energy this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here as elaborated below. You can see the complete list of today’s Zacks #1 Rank stocks here.
Vistra Corp. Price and EPS Surprise
Vistra Corp. price-eps-surprise | Vistra Corp. Quote
Earnings ESP: It has an Earnings ESP of -40.71%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Currently, Vistra Energy carries a Zacks Rank #3.
Stocks to Consider
Investors can consider the following players from the same sector that have the right combination of elements to beat on earnings this season.
Essential Utilities, Inc. (WTRG - Free Report) is set to release fourth-quarter earnings on Feb 24. It has an Earnings ESP of +3.60% and a Zacks Rank of 3, currently.
CenterPoint Energy, Inc. (CNP - Free Report) is expected to release fourth-quarter numbers on Feb 25. It has an Earnings ESP of +11.11% and a Zacks Rank #3, at present.
Sempra Energy (SRE - Free Report) is expected to release fourth-quarter numbers on Feb 25. It has an Earnings ESP of +6.45% and a Zacks Rank #3, at present.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>